A review of recent 13F filings for the 12/31/2025 period shows SCHG was held by 8 of the 24 sampled filers and that, across 4,163 funds tracked, aggregate SCHG holdings rose by 4,411,561 shares (from 326,117,064 to 330,528,625), a ~1.35% increase. The largest holders on 12/31/2025 were Mather Group (41,810,550 shares), Vantagepoint Investment Advisers (17,067,494) and Avantax Planning Partners (14,890,533); within the recent batch some funds opened new positions while others reduced or exited (e.g., Koesten Hirschmann & Crabtree exited). The write-up notes standard 13F limitations (long-only disclosure, shorts/derivatives not shown), making this a useful signal on positioning and flows but not a definitive bullish indicator.
Market structure: The modest aggregate inflow into SCHG (+4.41M shares, +1.35% of fund-held base between 9/30 and 12/31/2025) benefits large-cap growth names, index providers (Schwab) and liquidity providers; it slightly supports Nasdaq‑weighted instruments (QQQ, MGK) but is not broad enough to shift pricing power away from mega‑caps. Supply/demand is incremental not structural—top three holders (41.81M + 17.07M + 14.89M = ~73.8M shares) account for ~22% of hedge‑fund-held SCHG, concentrating risk if redemptions hit. Cross-asset: modest growth inflows typically compress IV in index options, put small downward pressure on Treasury yields in risk-on episodes and can modestly weaken USD if sustained. Risk assessment: Tail risks are a rapid rate re‑pricing (10y +50bp in 30 days) triggering >10% drawdowns in growth ETFs, or large redemptions from a handful of concentrated holders producing temporary liquidity premium spikes. Hidden dependencies: 13F long-only view masks short/derivative overlays—many managers may be net hedged, so long share-count increases do not equal directional conviction. Key catalysts that will accelerate reversal or confirmation are next 2 CPI prints and the Fed decision within 1–3 months, and any large institutional rebalancing announcement. Trade implications: Lean tactical long SCHG (Schwab U.S. Large‑Cap Growth ETF) for a 1–3 month window with tight risk controls; consider a relative pair long SCHG vs short SPY or IWD to isolate growth beta. Use options: buy 3‑month SCHG puts (≈7% OTM) or a 7/12% put spread to hedge tail risk if deploying >2% notional; sell short‑dated covered calls to monetize holdings if neutral near-term. Entry on a pullback >3% or if 10y yield retreats >10bp; trim on a 6–12% absolute gain or a 10y yield spike >50bp in 30 days. Contrarian angles: The market may be underestimating concentration and liquidity fragility—a 1.35% net increase masks that a few managers hold outsized shares, so crowding risk is underpriced. The increase is lukewarm, not a conviction surge; historical parallels (e.g., 2018 growth unwind) suggest a small trigger can cascade through levered derivative books. Unintended consequences include forced selling loops in underlying big cap names and cheapening of protection (puts) before realized volatility catches up.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.12
Ticker Sentiment
